Form 4: Procept BioRobotics Director Antal Rohit Desai Acquires Shares and Options

Director Antal Rohit Desai reports acquisition of common stock and stock options in Procept BioRobotics Corp.

Summary

• On June 4, 2024, Antal Rohit Desai, a director at Procept BioRobotics Corp, acquired 1,376 shares of common stock at $0 and 2,526 stock options with an exercise price of $67.29.
• The 1,376 shares were acquired as restricted stock units (RSUs) that vest in full on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting following the grant date, subject to continued service.
• The stock options also vest in full on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting following the grant date, subject to continued service, and expire on June 3, 2034.
• Following the transaction, Desai directly owns 59,183 shares of Procept BioRobotics Corp common stock and 2,526 stock options.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing detailing insider transactions. The acquisition of shares and options could be interpreted as a positive sign, but it's not definitively bullish.

Positives

• The acquisition of shares and options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The vesting schedule of the RSUs and stock options is contingent upon continued service, suggesting an expectation of ongoing involvement by the director.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company insiders, which can be informative for investors.

Stakeholder Impact

• Shareholders may view the insider's acquisition of shares and options as a positive signal.

Key Dates